Fungal otitis externa market is estimated to be valued at US$ 169.40 million in 2021 and is expected to exhibit a CAGR of 2.9% over the forecast period (2021-2028) | Novartis, Bayer AG, Sanofi, GlaxoSmithKline plc.

Market Overview

The diagnosis of fungal otitis externa is difficult for primary care physicians. The symptoms often mimic those of otitis media or bacterial otitis externa. If not diagnosed early, the condition can have a prolonged course and can lead to serious complications, such as perforations of the tympanic membrane. To help guide treatment, a doctor may prescribe a topical antibiotic or a combination of topical antifungal drugs. The treatment for fungal otitis externa involves a combination of antifungal, anti-inflammatory, and ear wax products. The first-line therapy is sofradex, while ciprofloxacin-based drops are used when the tympanic membrane is perforated.

Get FREE Sample Report with Latest Covid19 Impact Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/4548

Market Dynamics

A robust product pipeline is expected to drive growth of the global fungal otitis externa market during the forecast period. Key companies in the healthcare and pharmaceutical industries are focused on research and development activities with a robust product pipeline for the treatment of fungal otitis externa. For instance, in June 2020, Novus Therapeutics Inc., a U.S.-based pharmaceuticals company, announced topline results from the company’s exploratory phase 2a clinical trial of OP0201 in acute otitis externa. Therefore, these factors are expected to drive growth of the global fungal otitis external market during the forecast period.

However, increasing availability of generic medicines and complications related to drugs used in the treatment is expected to restrain growth of the global fungal otitis externa market during the forecast period.

Impact of COVID-19

The outbreak of the COVID-19 pandemic has negatively impacted growth of the global fungal otitis externa market. Following the pandemic, several countries implemented strict nationwide lockdown regulations. Manufacturing and construction activities were suspended temporarily, in order to curb the spread of the virus. Furthermore, the global supply chain industry witnessed a massive disruption due to restrictions on international trade and travel. However, recent relaxation in lockdown policies and declining cases can provide lucrative opportunities for potential growth.

Key Takeaways

• The global fungal otitis externa market is expanding rapidly, exhibiting a CAGR of 2.9% over the forecast period. This is owing to increasing incidence and prevalence of fungal otitis externa. According to the National Center for Biotechnology Information (NCBI), in March 2019, its prevalence was estimated at 10%.

Get PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/4548

• Among regions, Asia Pacific is expected to witness significant growth in the global fungal otitis externa market during the forecast period. This is owing to increasing geriatric population, which is the most vulnerable population to chronic infections such as fungal otitis externa.

• Key players involved in the global fungal otitis externa market are Novartis, Bayer AG,  Sanofi,  GlaxoSmithKline plc.,  AbbVie,  Par Pharmaceutical, Inc.,  Hi-Tech Pharma,  Actavis Mid-Atlantic, Hill Dermaceuticals Inc., NuLife Pharmaceuticals, Glenmark Pharmaceuticals Limited, Pfizer Inc., Janssen Pharmaceutical,  McNeil Consumer Healthcare,  Mylan N.V.,  and, Salvat Laboratories.

𝐂𝐡𝐫𝐢𝐬𝐭𝐦𝐚𝐬 𝐒𝐚𝐥𝐞 𝐈𝐬 𝐋𝐢𝐯𝐞!

𝐁𝐮𝐲 𝐍𝐨𝐰 𝐓𝐨 𝐀𝐯𝐚𝐢𝐥 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐅𝐫𝐨𝐦 𝟐𝟓-𝟑𝟎% 𝐭𝐢𝐥𝐥 𝟑𝟏-𝐃𝐞𝐜-𝟐𝟎𝟐𝟏

Purchase This Premium Report To Access Full Information @ https://www.coherentmarketinsights.com/insight/buy-now/4548

Table of Contents

1. Research Objectives and Assumptions
   • Research Objectives
   • Assumptions
   • Abbreviations
2. Market Purview
   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Market Snapshot, By Drug Type
     • Market Snapshot, By Fungus Type
     • Market Snapshot, By Route of Administration
     • Market Snapshot, By Distribution Channel
     • Market Snapshot, By Region
   • Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
     • Restraints
     • Market Opportunities
   • Impact Analysis
   • PEST Analysis
   • Industry Trends
   • Pipeline Analysis
   • Regulatory Scenario
   • Reimbursement Scenario
   • Epidemiology
   • Drug Price List
   • Treatment Algorithm
   • Physicians Preferences and Views
   • Global Supply Chain Analysis
   • U.S. Total Diagnosed Patients With Fungal Otitis Externa, By Age Group
   • U.S. Patient Rate Of Fungal Otitis Externa, By Season
   • SVT-15652 Market Value & Volume Forecast- Global
   • Insights and Methodology
4. Global Fungal Otitis Externa Market – Impact of Coronavirus (Covid-19) Pandemic
   
   • COVID-19 Epidemiology
   • Impact of Covid-19 on the Healthcare Sector
   • Impact of COVID-19 on Clinical Trials and Drug Development
5. Global Fungal Otitis Externa Market, By Drug Type, 2017 – 2028, (US$ Million) and Volume (No. of Units)
   • Overview
     • Market Share Analysis, 2021 and 2028 (%)
     • Y-o-Y Growth Analysis, 2018 – 2028
     • Segment Trends
   • Ear Drops
     • Overview
       • Market Size and Forecast, and Y-o-Y Growth, 2017–2028, (US$ Million) and Volume (No. of Units)
       • Clotrimazole
       • Fluconazole
       • Acetic Acid (2%)
   • Oral Medications
     • Overview
     • Market Size and Forecast, and Y-o-Y Growth, 2017–2028, (US$ Million) and Volume (No. of Units)
       • Itraconazole
       • NSAIDS
   • Topical Medications
     • Overview
     • Market Size and Forecast, and Y-o-Y Growth, 2017–2028, (US$ Million) and Volume (No. of Units)
   • Late Stage Pipeline Drugs
     • Overview
     • Market Size and Forecast, and Y-o-Y Growth, 2017–2028, (US$ Million) and Volume (No. of Units)
6. Global Fungal Otitis Externa Market, By Fungus Type, 2017 – 2028, (US$ Mn)
   • Overview
     • Market Share Analysis, 2021 and 2028 (%)
     • Y-o-Y Growth Analysis, 2018 – 2028
     • Segment Trends
   • Aspergillus
     • Overview
     • Market Size and Forecast, and Y-o-Y Growth, 2017–2028, (US$ Million)
   • Candida
     • Overview
     • Market Size and Forecast, and Y-o-Y Growth, 2017–2028, (US$ Million)
7. Global Fungal Otitis Externa Market, By Route of Administration, 2017 – 2028, (US$ Mn)
   • Overview
     • Market Share Analysis, 2021 and 2028 (%)
     • Y-o-Y Growth Analysis, 2018 – 2028
     • Segment Trends
   • Otic
     • Overview
     • Market Size and Forecast, and Y-o-Y Growth, 2017–2028, (US$ Million)
   • Oral
     • Overview
     • Market Size and Forecast, and Y-o-Y Growth, 2017–2028, (US$ Million)
   • Topical
     • Overview
     • Market Size and Forecast, and Y-o-Y Growth, 2017–2028, (US$ Million)
8. Global Fungal Otitis Externa Market, By Distribution Channel, 2017 – 2028, (US$ Mn)
   • Overview
     • Market Share Analysis, 2021 and 2028 (%)
     • Y-o-Y Growth Analysis, 2017 – 2028
     • Segment Trends
   • Hospital Pharmacies
     • Overview
     • Market Size and Forecast, and Y-o-Y Growth, 2017–2028, (US$ Million)
   • Retail Pharmacies
     • Overview
     • Market Size and Forecast, and Y-o-Y Growth, 2017–2028, (US$ Million)
   • Online Pharmacies
     • Overview
     • Market Size and Forecast, and Y-o-Y Growth, 2017–2028, (US$ Million)
9. Global Fungal Otitis Externa Market, By Region, 2017 – 2028, (US$ Mn)
   • Introduction
     • Market Share Analysis, By Region, 2021 and 2028 (%)
     • Y-o-Y Growth Analysis, For Regions, 2018–2028
     • Regional Trends
   • North America
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 – 2028, (US$ Million) and Volume (No. of Units)
     • Market Size and Forecast, and Y-o-Y Growth, By Fungus Type, 2017 – 2028, (US$ Million)
     • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 – 2028, (US$ Million)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2028, (US$ Million)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2028, (US$ Million)
       • U.S.
       • Canada
   • Latin America
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 – 2028, (US$ Million) and Volume (No. of Units)
     • Market Size and Forecast, and Y-o-Y Growth, By Fungus Type, 2017 – 2028, (US$ Million)
     • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 – 2028, (US$ Million)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2028, (US$ Million)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2028, (US$ Million)
       • Brazil
       • Mexico
       • Argentina
       • Rest of Latin America
   • Europe
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 – 2028, (US$ Million) and Volume (No. of Units)
     • Market Size and Forecast, and Y-o-Y Growth, By Fungus Type, 2017 – 2028, (US$ Million)
     • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 – 2028, (US$ Million)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2028, (US$ Million)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2028, (US$ Million)
       • UK
       • Germany
       • Italy
       • France
       • Spain
       • Russia
       • Rest of Europe
   • Asia Pacific
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 – 2028, (US$ Million) and Volume (No. of Units)
     • Market Size and Forecast, and Y-o-Y Growth, By Fungus Type, 2017 – 2028, (US$ Million)
     • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 – 2028, (US$ Million)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2028, (US$ Million)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2028, (US$ Million)
       • China
       • India
       • Japan
       • ASEAN
       • Australia
       • South Korea
       • Rest of Asia Pacific
   • Middle East
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 – 2028, (US$ Million) and Volume (No. of Units)
     • Market Size and Forecast, and Y-o-Y Growth, By Fungus Type, 2017 – 2028, (US$ Million)
     • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 – 2028, (US$ Million)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2028, (US$ Million)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2028, (US$ Million)
       • GCC
       • Israel
       • Rest of Middle East
   • Africa
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 – 2028, (US$ Million) and Volume (No. of Units)
     • Market Size and Forecast, and Y-o-Y Growth, By Fungus Type, 2017 – 2028, (US$ Million)
     • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 – 2028, (US$ Million)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2028, (US$ Million)
     • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 – 2028, (US$ Million)
       • North Africa
       • Central Africa
       • South Africa

About Us:

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837